Full Title
Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE) (A032302) (CIRB)Purpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Kristine Lacuna’s office at 646-227-2417.
Protocol
25-389
Phase
Phase III (phase 3)
Investigator
Co-Investigators
Diseases
ClinicalTrials.gov ID
NCT06931340